Skip to main content

Advertisement

SpringerLink
Log in

Hormone Treatment and Alzheimer’s Disease: Déjà Vu or Confused All Over Again?

  • Commentary
  • Published:
Drugs & Aging Aims and scope Submit manuscript

The Original Article was published on 03 August 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. With the possible exception of undergoing surgical or chemical menopause at a younger age without estrogen treatment up to the natural age of menopause at 51 years. [14]

References

  1. Caldwell BM, Watson RI. An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months. J Gerontol. 1952;7:228–44.

    Article  CAS  Google Scholar 

  2. Caldwell BM. An evaluation of psychological effects of sex hormone administration in aged women. II. Results of therapy after 18 months. J Gerontol. 1954;9(2):168–74.

    Article  CAS  Google Scholar 

  3. Sherwin BB. Estrogenic effects on memory in women. Ann N Y Acad Sci. 1994;743:213–30.

    Article  CAS  Google Scholar 

  4. Kantor HI, Michael CM, Shore E. Estrogen for older women. Am J Obstet Gynecol. 1973;4:31–47.

    Google Scholar 

  5. Hogervorst E, Yaffe K, Richards M, et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev. 2002;3:CD003122.

    Google Scholar 

  6. Ohkura T, Isse K, Akazawa K, et al. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1994;1:125–30.

    Google Scholar 

  7. Asthana S, Craft S, Baker LD, et al. Cognitive and neuroedocrine response to transdermal estrogen in postmenopausal women with AD: results of a placebo-controlled, double-blind pilot study. Psychoneuroendocrinology. 1999;24:657–77.

    Article  CAS  Google Scholar 

  8. Hogervorst E, Williams J, Combrinck M, David Smith A. Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol. 2003;148(1):67-72. https://doi.org/10.1530/eje.0.1480067. PMID: 12534359

    Article  CAS  Google Scholar 

  9. Barrett-Connor E. Rethinking estrogen and the brain. JAGS. 1998;46:918–20.

    Article  CAS  Google Scholar 

  10. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA. 2003;289:2651–62.

    Article  CAS  Google Scholar 

  11. Cardinali CA, Akamine-Martins Y, Torrão AS. Use of hormone therapy in postmenopausal women with Alzheimer’s disease: a systematic review. Drugs Aging. 2021;38(9). https://doi.org/10.1007/s40266-021-00878-y

  12. Hogervorst E, Yaffe K, Richards M, et al. HRT to maintain cognitive function in women with dementia. Cochrane Database Syst Rev. 2009;21(1):CD003799.

    Google Scholar 

  13. Hogervorst E, Boshuisen M, Riedel WJ, et al. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology. 1999;24:43–68.

    Article  CAS  Google Scholar 

  14. Hogervorst E, Henderson VW, Gibbs RB, et al. Hormones, cognition and dementia. Cambridge: Cambridge University Press; 2019.

    Google Scholar 

  15. McEwen BS, Woolley CS. Estradiol and progestrone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol. 1994;29(3–4):431–6.

    Article  CAS  Google Scholar 

  16. Petitti DB, Buckwalter GJ, Crooks VC, et al. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Biol Sci Med Sci. 2002;57(8):M532–8.

    Article  Google Scholar 

  17. Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.

    Article  CAS  Google Scholar 

  18. Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy: are users healthier than nonusers? Am J Epidemiol. 1996;143(10):971–8.

    Article  CAS  Google Scholar 

  19. Livingston G, Huntley J, Somerlad A, et al. Dementia prevention, intervention and care. Lancet. 2020;396(10248):413–46.

    Article  Google Scholar 

  20. Irving K, Hogervorst E, Oliveira D, et al. New developments in dementia prevention research. New York: Routledge; 2018.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Centre for Sports and Exercise Medicine, School for Sports, Exercise and Health Sciences, Loughborough University, Ashby Road, Loughborough, Staffordshire, LE11 3TU, UK

    Eef Hogervorst

Authors
  1. Eef Hogervorst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eef Hogervorst.

Ethics declarations

Funding

Eef Hogervorst received funding from the Alzheimer’s Association, Newton Trust and British Council for her work on (phyto)oestrogens. No funding was specifically received for the publication of this commentary.

Conflict of interest

Eef Hogervorst has no conflicts of interest that are directly relevant to the content of this commentary.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Code avail ability

Not applicable.

Author contributions

EH is the sole author of this commentary.

Additional information

This comment refers to the article available at https://doi.org/10.1007/s40266-021-00878-y.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hogervorst, E. Hormone Treatment and Alzheimer’s Disease: Déjà Vu or Confused All Over Again?. Drugs Aging 38, 793–795 (2021). https://doi.org/10.1007/s40266-021-00887-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-021-00887-x

Search

Navigation